The Beauty Health Company (NASDAQ:SKIN – Get Rating) – Equities researchers at Jefferies Financial Group upped their Q4 2022 earnings per share (EPS) estimates for shares of Beauty Health in a research note issued to investors on Tuesday, May 10th. Jefferies Financial Group analyst S. Wissink now forecasts that the company will post earnings of $0.07 per share for the quarter, up from their previous forecast of $0.03. Jefferies Financial Group also issued estimates for Beauty Health’s Q1 2023 earnings at ($0.08) EPS, Q3 2023 earnings at $0.10 EPS and Q4 2023 earnings at $0.13 EPS.
Beauty Health (NASDAQ:SKIN – Get Rating) last issued its earnings results on Tuesday, May 10th. The company reported ($0.06) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.05). The company had revenue of $75.40 million during the quarter, compared to analyst estimates of $68.15 million. Beauty Health had a negative return on equity of 0.01% and a negative net margin of 117.84%. The business’s revenue for the quarter was up 58.7% on a year-over-year basis.
A number of other equities analysts have also recently issued reports on SKIN. JPMorgan Chase & Co. initiated coverage on Beauty Health in a report on Friday, March 11th. They issued an “overweight” rating and a $24.00 target price on the stock. Piper Sandler lowered their price target on Beauty Health from $26.00 to $24.00 in a report on Wednesday. Canaccord Genuity Group lowered their price target on Beauty Health from $27.00 to $22.00 in a report on Wednesday. Benchmark lifted their price target on Beauty Health from $18.00 to $23.00 and gave the company a “buy” rating in a report on Monday, March 14th. Finally, Zacks Investment Research downgraded Beauty Health from a “buy” rating to a “hold” rating in a report on Thursday. Two equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $25.55.
Shares of NASDAQ SKIN opened at $10.63 on Friday. The company has a debt-to-equity ratio of 2.41, a quick ratio of 12.63 and a current ratio of 13.09. The stock’s fifty day simple moving average is $15.68 and its 200 day simple moving average is $19.21. Beauty Health has a 52-week low of $9.94 and a 52-week high of $30.17.
Several large investors have recently made changes to their positions in SKIN. William Blair Investment Management LLC lifted its position in shares of Beauty Health by 232.2% in the fourth quarter. William Blair Investment Management LLC now owns 6,251,906 shares of the company’s stock worth $151,046,000 after buying an additional 4,370,217 shares during the last quarter. Marshall Wace LLP bought a new position in shares of Beauty Health in the third quarter worth about $106,826,000. BlackRock Inc. increased its stake in Beauty Health by 117.8% during the third quarter. BlackRock Inc. now owns 7,526,320 shares of the company’s stock valued at $195,459,000 after acquiring an additional 4,071,277 shares during the period. Invesco Ltd. increased its stake in Beauty Health by 21,048.1% during the third quarter. Invesco Ltd. now owns 3,448,200 shares of the company’s stock valued at $89,550,000 after acquiring an additional 3,431,895 shares during the period. Finally, Lord Abbett & CO. LLC bought a new position in Beauty Health during the third quarter valued at about $56,687,000. 72.01% of the stock is owned by institutional investors.
Beauty Health Company Profile (Get Rating)
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company’s flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums.
Receive News & Ratings for Beauty Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Beauty Health and related companies with MarketBeat.com’s FREE daily email newsletter.